EUVIMEDEUVIMED entdecken
Leitlinie

Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society

Julie A Miller, Justin Gundara, Simon Harper, Madhuni Herath, Sabashini K Ramchand, Stephen Farrell, Jonathan Serpell, Kim Taubman, James Christie, Christian M Girgis, Hans G Schneider, Roderick Clifton-Bligh und 5 weitere

Clinical Endocrinology · 2024-11 · 101 (5) · 516-530

DOI: 10.1111/cen.14650 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Clinical Endocrinology, online erschienen am 19.12.2021. Verfasst von Julie A Miller und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary, Parathyroidectomy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 124 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To develop evidence‐based recommendations to guide the surgical management and postoperative follow‐up of adults with primary hyperparathyroidism.

Methods

Representatives from relevant Australian and New Zealand Societies used a systematic approach for adaptation of guidelines (ADAPTE) to derive an evidence‐informed position statement addressing eight key questions.

Results

Diagnostic imaging does not determine suitability for surgery but can guide the planning of surgery in suitable candidates. First‐line imaging includes ultrasound and either parathyroid 4DCT or scintigraphy, depending on local availability and expertise. Minimally invasive parathyroidectomy is appropriate in most patients with concordant imaging. Bilateral neck exploration should be considered in those with discordant/negative imaging findings, multi‐gland disease and genetic/familial risk factors. Parathyroid surgery, especially re‐operative surgery, has better outcomes in the hands of higher volume surgeons. Neuromonitoring is generally not required for initial surgery but should be considered for re‐operative surgery. Following parathyroidectomy, calcium and parathyroid hormone levels should be re‐checked in the first 24 h and repeated early if there are risk factors for hypocalcaemia. Eucalcaemia at 6 months is consistent with surgical cure; parathyroid hormone levels do not need to be re‐checked in the absence of other clinical indications. Longer‐term surveillance of skeletal health is recommended.

Conclusions

This position statement provides up‐to‐date guidance on evidence‐based best practice surgical and postoperative management of adults with primary hyperparathyroidism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperparathyroidism, PrimaryParathyroidectomyHumansNew ZealandAustraliaAdultSocieties, MedicalEndocrinologyPostoperative Period

Autor:innen und Institutionen

  • Department of Surgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Department of Surgery, University of Melbourne, Melbourne, Victoria, Australia.
  • Endocrine Surgical Centre, Epworth Hospital Network, Richmond, Victoria, Australia.
  • Department of Surgery, Redland Hospital, Metro South and Faculty of Medicine, University of Queensland, Saint Lucia, Queensland, Australia.
  • Department of Surgery, Logan Hospital, Metro South and School of Medicine and Dentistry, Griffith University, Nathan, Queensland, Australia.
  • Department of General Surgery, Wellington Regional Hospital, Wellington, New Zealand.

Zitieren

APA

Miller, J. A., Gundara, J., Harper, S., Herath, M., Ramchand, S. K., Farrell, S., Serpell, J., Taubman, K., Christie, J., Girgis, C. M., Schneider, H. G., Clifton-Bligh, R., Gill, A. J., De Sousa, S. M. C., Carroll, R. W., Milat, F., & Grossmann, M. (2024). Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society. Clinical Endocrinology, 101(5), 516-530. https://doi.org/10.1111/cen.14650

Vancouver

Miller JA, Gundara J, Harper S, Herath M, Ramchand SK, Farrell S, et al. Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society. Clinical Endocrinology. 2024;101(5):516-530. doi:10.1111/cen.14650

BibTeX
@article{Miller2024,
  author = {Miller, Julie A and Gundara, Justin and Harper, Simon and Herath, Madhuni and Ramchand, Sabashini K and Farrell, Stephen and Serpell, Jonathan and Taubman, Kim and Christie, James and Girgis, Christian M and Schneider, Hans G and Clifton-Bligh, Roderick and Gill, Anthony J and De Sousa, Sunita M C and Carroll, Richard W and Milat, Frances and Grossmann, Mathis},
  title = {Primary hyperparathyroidism in adults—(Part II) surgical management and postoperative follow‐up: Position statement of the Endocrine Society of Australia, The Australian & New Zealand Endocrine Surgeons, and The Australian & New Zealand Bone and Mineral Society},
  journal = {Clinical Endocrinology},
  year = {2024},
  volume = {101},
  number = {5},
  pages = {516--530},
  doi = {10.1111/cen.14650}
}
Kostenlos starten →